What medication is linked to an increased dementia risk?

Proton pump inhibitors (PPIs), a common medication used to reduce stomach acid and treat acid reflux, have been linked to an increased dementia risk in long-term users.

How long does PPI use increase dementia risk?

The study found a higher risk of dementia associated with taking proton pump inhibitors for more than 4.4 years.

Is there a definite causal link between PPIs and dementia?

No, the research indicates a correlation between long-term PPI use and an increased risk of dementia, but it does not establish a causal link. Further research is needed.

Home / Health / Common UK Drug Linked to 33% Higher Dementia Risk

Common UK Drug Linked to 33% Higher Dementia Risk

14 Feb

•

Summary

Long-term use of PPIs may increase dementia risk by 33%.
Study monitored 5,712 participants for over 5 years.
Correlation, not causation, established between PPIs and dementia.

Common UK Drug Linked to 33% Higher Dementia Risk

A widely-used medication in the UK, commonly prescribed for acid reflux, may be associated with a substantially elevated risk of dementia. New research published in the journal Neurology indicates that individuals using proton pump inhibitors (PPIs) for more than 4.4 years face a 33% greater chance of developing dementia. This finding emerged from a study involving 5,712 participants aged 45 and above, all initially free of dementia. The average age of participants was 75, and they were followed for an average of 5.5 years.

The study categorized participants based on their PPI usage patterns. Researchers observed that those taking PPIs for over 4.4 years experienced a higher incidence of dementia compared to non-users. Specifically, 24 cases per 1,000 person-years were noted in the long-term users, against 19 cases per 1,000 person-years in those who never took the medication. This increased risk persisted even after accounting for other health factors.